BMS 181174-d4 is labelled BMS 181174 (B595910), an analog of Mitomycin C (M371900) with activity against a range of tumor cell lines and xenografts, including MMC-resistant tumors. However, phase I clinical trials from Bristol-Myers Squibb demonstrated that the toxicity profile of BMS 181174 was no more favourable than that of mitomycin.
Molecular Formula:C23H21D4N5O7S2
Molecular Weight:551.63
Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
